The excess costs of breast cancer health care in Hispanic and non-Hispanic female members of a managed care organization.
The excess costs of breast cancer health care in Hispanic and non-Hispanic female members of a managed care organization.
复制标题
管理医疗组织的西班牙裔和非西班牙裔女性成员乳腺癌医疗保健的超额费用。
DOI：
10.1023/a:1010656131424
复制
发表时间：
2001
影响因子：
3.8
通讯作者：
Petersen,HV
中科院分区：
文献类型：
--
作者：
Tollestrup,K;Frost,FJ;Stidley,CA;Bedrick,E;McMillan,G;Kunde,T;Petersen,HV
估计管理式医疗机构的西班牙裔和非西班牙裔成员的乳腺癌妇女和非乳腺癌妇女之间的医疗保健服务费用差异。使用全面的患者数据库，共选择了317例乳腺癌和949例对照。获得了病例诊断前4-12个月和病例诊断后12个月的所有医疗保健费用。费用被定义为保健计划的费用。使用Tobit模型预测病例组和对照组在诊断前4-12个月和诊断后一年的总医疗费用的平均差异。与对照组相比，所有年龄组中被诊断为原位乳腺癌的妇女在诊断前4-12个月的医疗保健费用显着增加。对于50岁以下的女性，诊断后12个月，与对照组相比，区域/远处疾病的女性患者的成本差异（17，093 ± 1，559美元）几乎是原位疾病（5，089 ± 1，050美元）的3倍。对于其他两个年龄组（50-70岁和70岁以上）的妇女，与原位疾病内的妇女相比，患有区域/远处疾病的妇女的差异是其两倍多。西班牙裔和非西班牙裔妇女在疾病的各个阶段诊断后12个月的医疗费用的病例和对照组之间的平均差异相似。
The differences in costs for health care services between women with breast cancer and those without were estimated for Hispanic and non-Hispanic members of a managed care organization. A total of 317 cases of breast cancer and 949 controls were selected using a comprehensive patient database. All health care costs for the 4–12 months prior to the case's diagnosis and for the 12 months following the case's diagnosis were obtained. Costs were defined as charges to the health plan. Mean differences in total health care costs between cases and controls were predicted using Tobit models for 4–12 months prior to diagnosis and the year after diagnosis by age group. Compared to controls, women diagnosed within situbreast cancers in all age groups had significantly higher health care costs 4–12 months prior to diagnosis. For women under 50 years of age, the difference in costs for cases compared to controls 12 months after diagnosis was almost three times greater for women with regional/distant disease ($ 17,093 ± $ 1,559) compared toin situdisease ($ 5,089 ± $ 1,050). For women in the two other age groups (50–70 years and over 70 years), the difference was over twice as great for those with regional/distant disease compared to those within situdisease. Mean differences between cases and controls in health care costs 12 months after diagnosis were similar for Hispanic and non-Hispanic women for all stages of disease.